Cancer Treatment Results  Survival Rates Cancer Treatments / Therapy Results
Cancer
 
Search Results



Your search returned 1870 record(s).

Page 181 of 187  |  Previous Page   |  Next Page

Cancer Type:   Sort By:

This Search was Made Possible by:


  Survival: Patients: Toxicity: Treatment: Hospital: Country: Date:
1801 ? Locally advanced rectal cancer 4 Chemotherapy
Radiation
Mount Vernon Cancer Centre United Kingdom 1/2006
Treatment Details: Patients: This Phase I study involved 18 patients with locally advanced rectal cancer. Twelve patients were men, six were women, and the median age was 56.8 years. Treatment: The treatme
 
1802 ? metastatic rcc 4 Chemotherapy
Immunotherapy
Antoni van Leeuwenhoek Hospital Netherlands 9/2005
Treatment Details: Patients: This phase II study involved 22 patients with metastatic renal cancer. Fifteen were men, and seven were women. Metastatic sites include lung, lymph nodes, liver, and bone. The m
 
1803 ? hepatocellular carcinoma 3 Biologic therapy
Radiation
Ghent University Hospital Belgium 1/2005
Treatment Details: Patients: This Phase I study involved 11 patients with hepatocellular carcinoma, 8 men and 3 women. Treatment: Treatment consisted of the intraarterial administration of (188)Re-labeled
 
1804 ? ovarian cancer 4 Chemotherapy
National Cancer Institute United States 5/2005
Treatment Details: Patients: This phase I study involved 26 patients with advanced solid tissue cancers, including colorectal (6), ovarian (4), and breast (4). All patients had received treatment before the st
 
1805 ? advanced ovarian cancer 3 Chemotherapy
University Hospital of Groningen Netherlands 4/2005
Treatment Details: Patients: This Phase II study involved 90 women with advanced ovarian cancer. The patients were randomly placed into two groups. Group A (45 patients) had a median age of 60. None of the
 
1806 ? advanced ovarian cancer 3 Chemotherapy
University Hospital of Groningen Netherlands 4/2005
Treatment Details: Patients: This Phase II study involved 90 women with advanced ovarian cancer. The patients were randomly placed into two groups. Group B (45 patients) had a median age of 59. None of the
 
1807 ? advanced ovarian cancer 4 Chemotherapy
University Hospital of Groningen Netherlands 3/2005
Treatment Details: Patients: This Phase I study involved 21 women with advanced ovarian cancer. The median age was 51. Treatment: The treatment consisted of three chemotherapeutic drugs: topotecan, carbopl
 
1808 ? resected metastatic melanoma 3 Immunotherapy
University of Southern California United States 4/2003
Treatment Details: Patients: This Phase II study involved 15 patients with resected metastatic melanoma. Treatment: The treatment consisted of a multipeptide vaccine administered with progenipoietin an ag
 
1809 ? Various high-grade gliomas 4 Chemotherapy
University of Texas Southwestern Medical Center United States 4/2001
Treatment Details: Patients: This Phase I trial included 45 patients, 43 of which were evaluable for response. These 43 patients were comprised of 25 patients with glioblastoma multiforme, 9 patients with met
 
1810 ? Various brain tumors Chemotherapy
Osaka Medical Center for Cancer and Cardiovascular Diseases Japan 6/2001
Treatment Details: Patients: There were a total of 13 patients in this study comprised of six patients with glioblastoma, one patient with anaplastic astrocytoma and six patients with other metastatic brain tu
 
Page 181 of 187  | Previous Page  | Next Page